Erste Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $67.9M | Sell |
267,697
-28,950
| -10% | -$6.23M | 0.53% | 41 |
|
|
2026
Q1 | $63.2M | Buy |
296,647
+23,072
| +8% | +$5.12M | 0.59% | 40 |
|
|
2025
Q4 | $63M | Sell |
273,575
-23,892
| -8% | -$5.44M | 0.53% | 46 |
|
|
2025
Q3 | $66.3M | Sell |
297,467
-106,375
| -26% | -$21.7M | 0.64% | 36 |
|
|
2025
Q2 | $73.8M | Buy |
403,842
+164,575
| +69% | +$30.6M | 0.62% | 34 |
|
|
2025
Q1 | $49.2M | Buy |
239,267
+99,318
| +71% | +$19.3M | 0.63% | 44 |
|
|
2024
Q4 | $24.9M | Buy |
139,949
+9,765
| +8% | +$1.8M | 0.31% | 80 |
|
|
2024
Q3 | $25.4M | Buy |
130,184
+7,076
| +6% | +$1.32M | 0.3% | 83 |
|
|
2024
Q2 | $20.8M | Buy |
123,108
+3,304
| +3% | +$547K | 0.28% | 89 |
|
|
2024
Q1 | $21.6M | Buy |
119,804
+1,411
| +1% | +$243K | 0.29% | 95 |
|
|
2023
Q4 | $18.3M | Buy |
118,393
+54,448
| +85% | +$7.94M | 0.27% | 105 |
|
|
2023
Q3 | $9.73M | Buy |
63,945
+3,063
| +5% | +$450K | 0.17% | 142 |
|
|
2023
Q2 | $8.11M | Sell |
60,882
-45,523
| -43% | -$6.68M | 0.14% | 160 |
|
|
2023
Q1 | $16.8M | Buy |
106,405
+2,451
| +2% | +$375K | 0.32% | 92 |
|
|
2022
Q4 | $16.9M | Buy |
103,954
+2,376
| +2% | +$364K | 0.36% | 81 |
|
|
2022
Q3 | $14.5M | Buy |
101,578
+219
| +0.2% | +$31.4K | 0.32% | 89 |
|
|
2022
Q2 | $15.6M | Sell |
101,359
-7,109
| -7% | -$1.09M | 0.35% | 84 |
|
|
2022
Q1 | $17.8M | Sell |
108,468
-4,843
| -4% | -$703K | 0.34% | 84 |
|
|
2021
Q4 | $15.3M | Sell |
113,311
-227
| -0.2% | -$26.8K | 0.28% | 102 |
|
|
2021
Q3 | $12.4M | Buy |
113,538
+10,970
| +11% | +$1.25M | 0.24% | 118 |
|
|
2021
Q2 | $11.5M | Buy |
102,568
+28,522
| +39% | +$3.21M | 0.23% | 122 |
|
|
2021
Q1 | $7.91M | Buy |
74,046
+820
| +1% | +$87.7K | 0.19% | 139 |
|
|
2020
Q4 | $7.67M | Buy |
73,226
+8,739
| +14% | +$840K | 0.21% | 131 |
|
|
2020
Q3 | $5.6M | Buy |
64,487
+5,517
| +9% | +$519K | 0.19% | 133 |
|
|
2020
Q2 | $5.69M | Buy |
58,970
+39,280
| +199% | +$3.46M | 0.23% | 125 |
|
|
2020
Q1 | $1.48M | Sell |
19,690
-5,500
| -22% | -$468K | 0.09% | 212 |
|
|
2019
Q4 | $2.25M | Buy |
25,190
+15,000
| +147% | +$1.25M | 0.1% | 199 |
|
|
2019
Q3 | $764K | Buy |
10,190
+7,300
| +253% | +$500K | 0.04% | 287 |
|
|
2019
Q2 | $206K | Sell |
2,890
-12,892
| -82% | -$1.01M | 0.01% | 364 |
|
|
2019
Q1 | $1.26M | Sell |
15,782
-3,060
| -16% | -$250K | 0.07% | 223 |
|
|
2018
Q4 | $1.7M | Buy |
+18,842
| New | +$1.66M | 0.11% | 175 |
|
Other funds holding ABBV
Erste Asset Management's ABBV Position: Q2 2026 in Review
Erste Asset Management reduced its AbbVie (ABBV) stake by 9.8% in Q2 2026, selling an estimated $6.23M and leaving 267,697 shares worth $67.9M. The position accounts for 0.53% of the portfolio, ranked #41.
Erste Asset Management first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $73.8M in Q2 2025. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Erste Asset Management held 267,697 shares of AbbVie worth $67.9M as of Q2 2026.
- Erste Asset Management sold 28,950 AbbVie shares in Q2 2026, an estimated $6.23M.
- AbbVie made up 0.53% of Erste Asset Management's portfolio in Q2 2026, its #41 holding.
- Erste Asset Management first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- Erste Asset Management's AbbVie position peaked at $73.8M in Q2 2025.
- 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.